Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial (Q79078816)
Jump to navigation
Jump to search
scientific article published on 01 September 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial |
scientific article published on 01 September 2003 |
Statements
Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial (English)
Manuel Bardiès
Françoise Kraeber-Bodéré
Alain Faivre-Chauvet
Ludovic Ferrer
Jean-Philippe Vuillez
Pierre-Yves Brard
Caroline Rousseau
Isabelle Resche
Anne Devillers
Sophie Laffont
Ken Chang
Jean-François Chatal
Jacques Barbet
Robert M. Sharkey
David M. Goldenberg
1 September 2003